U.N. Must Promote Harm Reduction As HIV Prevention Strategy Among Drug Users

The Guardian: To end HIV in drug users, stop chasing the dream of a drug-free world
Susie McLean, senior adviser on drug use and HIV for the International HIV/AIDS Alliance

“…The evidence for the effectiveness of harm reduction interventions — reducing the negative consequences of drug use rather than focusing solely on reducing drug use — is described by UNAIDS as irrefutable and all relevant U.N. agencies now endorse a harm reduction approach to HIV and drug use. … Yet in Vienna last week, references to harm reduction, needle and syringe programs, and opioid substitution therapy (OST) were contested. The policy process has been widely criticized, and the negotiations heavily influenced by countries including Russia who are vetoing harm reduction in favor of a bald restatement of the decades-old illusion of a drug-free world. … [I]t’s unbelievable that U.N. member states are likely to recommit to another ineffective and dangerous policy on drugs when it is put before them in New York next month, at the first U.N. General Assembly special session on drugs. While this strange corner of the U.N. system in Vienna continues to promote the fantasy of a drug-free world, we will continue to urge states to commit to two words: harm reduction” (3/21).

The KFF Daily Global Health Policy Report summarized news and information on global health policy from hundreds of sources, from May 2009 through December 2020. All summaries are archived and available via search.

KFF Headquarters: 185 Berry St., Suite 2000, San Francisco, CA 94107 | Phone 650-854-9400
Washington Offices and Barbara Jordan Conference Center: 1330 G Street, NW, Washington, DC 20005 | Phone 202-347-5270

www.kff.org | Email Alerts: kff.org/email | facebook.com/KFF | twitter.com/kff

The independent source for health policy research, polling, and news, KFF is a nonprofit organization based in San Francisco, California.